Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $115

Benzinga · 08/04 10:37
Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $113 to $115.